Evaluation of Patients Who Have Not Had Success With Zidovudine

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 1995

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (18)

13210

SUNY / State Univ of New York, Syracuse

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

35294

Univ of Alabama at Birmingham, Birmingham

55455

Univ of Minnesota, Minneapolis

60611

Children's Mem Hosp Family Cln / Northwestern Univ Med Schl, Chicago

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

80262

Kaiser Permanente Franklin Med Ctr, Denver

Univ of Colorado Health Sciences Ctr, Denver

112032098

SUNY / Health Sciences Ctr at Brooklyn, Brooklyn

681985130

Univ of Nebraska Med Ctr, Omaha

941102859

San Francisco Gen Hosp, San Francisco

943055107

San Mateo AIDS Program / Stanford Univ, Stanford

951282699

Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose

981224304

Univ of Washington, Seattle

01199

Baystate Med Ctr of Springfield, Springfield

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH